Valvular & structural heart disease
Practice Patterns and Outcomes for Tricuspid Interventions Among Medicare Patients With Cardiac Implantable Electronic Devices
Main finding · Procedural complications, concomitant extraction vs no extraction (patients with CIEDs)Result — go to the resultAdjusted odds ratio 1.61 95% CI 1.31–1.98Authors' conclusion
The nationwide volume of percutaneous tricuspid interventions is increasing, driven primarily by patients with CIEDs, who represent approximately 10% of the tricuspid procedural volume. Concomitant lead extraction was frequently used when clinically indicated and was not associated with higher complications.
Study context
- Population
- Medicare beneficiaries undergoing surgical or percutaneous tricuspid interventions, 2016–20232,355 (9.2%) with cardiac implantable electronic devices (CIEDs)
- Participants
- 25,910 beneficiaries
- Exposure
- Tricuspid intervention with vs without concomitant CIED extraction; patients with vs without CIEDs
- CIEDsn = 2,355
- Outcome
- In-hospital and 30-day procedural complications
- Follow-up
- In-hospital and 30 days
Methodological detailspropensity score models, Medicare beneficiaries, nationwide
- Propensity score models
- Medicare beneficiaries
- Nationwide
Main finding
As reported in the abstract
Procedural complications, concomitant extraction vs no extraction (patients with CIEDs) · in-hospital
Adjusted odds ratio
1.61
95% CI 1.31–1.98
Extraction vs No extraction
adjusted OR 1.61 (95% CI 1.31–1.98)
Observational data: associations, not effects.
Further findings
Percutaneous tricuspid interventions
- Percutaneous tricuspid interventions — Percutaneous share of tricuspid interventions, 2016 to 2023
- <1% to 28%
Tricuspid intervention plus extraction (patients with CIEDs)
- Extraction performed
- 18.9%
- CIED infection, most common predictor of extraction
- 35.8%
Safety
Complications, all tricuspid interventions
- Death
- 1.1%
- Shock
- 14.1%
- Bleeding requiring transfusion
- 8.7%
Original publication
Practice Patterns and Outcomes for Tricuspid Interventions Among Medicare Patients With Cardiac Implantable Electronic Devices. JACC Clin Electrophysiol. Published 7 November 2025. doi:10. 1016/ j. jacep. 2025. 09. 025
Summarised from the published abstract; every number is checked against it